By 10:17 a.m. Eastern Time-right around the time most people are contemplating whether to pour another cup of coffee or pour themselves into an existential crisis-Lucid shares had plunged by 7.5%. That’s after an earlier, more energetic tumble of 10.7%. For those keeping score at home, that’s a downward trajectory so steep it could make a rollercoaster designer blush.
Heading into the latest quarter, Wall Street pundits confidently predicted a modest $0.65 per share, adjusting to smooth out any one-time hiccups. Arista, however, decided to RSVP to that with a raucous “Hold my beer” and delivered a hefty $0.73 per share, alongside a tidy $2.2 billion in revenue-another reminder that, sometimes, being slightly better than ‘good enough’ can turn heads faster than a viral TikTok trend.
Berkshire Hathaway’s success under Buffett was as much a product of his era as it was of his acumen. The same cannot be said for the current climate, where economic tides shift with the whims of central banks and consumer confidence. Still, the myth endures. For those who believe Buffett’s picks are infallible, the recent performance of Visa and American Express offers both vindication and warning.
Yet here we stand, at the precipice of folly, asking: Is it too late to partake in this modern-day gold rush? A question as sensible as asking if the moon is too far to dance upon. For if you believe Bitcoin’s tale, you must also believe in perpetual motion, in the philosopher’s stone, in the notion that scarcity alone can fill a man’s purse-or his head.
But here’s the thing about hope: it doesn’t always pay dividends. If you’d taken $1,000 and thrown it at Pfizer’s stock back in August 2020, when everyone was desperate for good news, your investment would now be worth around $638. That’s right-less than what you started with. Sure, Pfizer’s dividend offered some comfort, nudging your total up to $828. But let’s face it: that’s still not something you’d write home about.
Market close on July 2, 2025, set the stage-who knew a share price of $164.92 could feel so much like a badge of honor? Unless you’re a day trader, it’s just a number, until it isn’t.
Now, I’m aware that jumping headlong into the semiconductor sector might seem about as daring as auctioning off one’s inherited silverware during the champagne cork pop, but Nvidia presents a case of clever stability dressed up as a roaring bull. With the current landscape, its prospects don’t just shimmer-they gleam, even if the industry’s current enthusiasm might suggest otherwise.
Back in May, the drama played out again-shares nose-dived 6.2% after the management politely refused to hand out a full-year roadmap, citing macroeconomic fog and the semiconductor sector’s shivers. Now, add another layer of disappointment: Q1 results merely matched expectations-$1.05 billion in revenue, a tidy 12% lift, but just enough to keep the lights on. Earnings per share? A modest decline from $0.40 to $0.35. All in the context of a sharp increase in R&D-up 48%, throwing money into the abyss-$440 million like an offering to the silicon gods, hoping for some divine intervention down the line. Some investors looked at the rising expenses and saw red-what’s the point of funding research when the stock’s bleeding out? But that’s the reckless, beautiful gamble-because Arm, in its madness, might just be manufacturing the seeds of its own resurrection.
See, the market’s irrational. Some days it’s like a happy drunk at a wedding, stumbling in every direction, while on other days it’s eerily sober, calculating every move. But dividends? They’re the calm in the chaos. They keep paying out, quarter after quarter, no matter what the stock gods are doing. That’s a kind of relief. And when you want to take a bit of the guesswork out of investing, it’s not a bad idea to look at a dividend-focused exchange-traded fund (ETF). With $100 to spare, the Schwab U.S. Dividend Equity ETF (SCHD) might be worth your consideration. Why? Let’s unpack it.
Indeed, the market is aflutter-showcasing not just a smattering, but a symphony of stablecoins-over ten now boasting market caps surpassing $450 million. Investors, caught in the glittering allure, must peer beyond the shimmering surface and consider the stark, unromantic truth: these coins are tethered to the dollar, unwavering, unyielding-ceaselessly worth one dollar. The immortal phrase echoes, regardless of popularity or utility, “a dollar is a dollar.”